Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ionotropic glutamate receptors.

C F Bigge1

  • 1Parke-Davis Pharmaceutical Research, Warner-Lambert Company, 2800 Plymouth Road, Ann Arbor, Michigan, 48105, USA. Christopher.bigge@WL.com

Current Opinion in Chemical Biology
|July 27, 1999
PubMed
Summary

Ionotropic glutamate receptors, crucial for brain signaling, are being studied for their binding sites and how they function. New selective drugs are unlocking the mysteries of kainate receptor pharmacology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

4-Hydroxy-1-[2-(4-hydroxyphenoxy)ethyl]-4-(4-methylbenzyl)piperidine: a novel, potent, and selective NR1/2B NMDA receptor antagonist.

Journal of medicinal chemistry·1999
Same author

Subtype-selective N-methyl-D-aspartate receptor antagonists: synthesis and biological evaluation of 1-(arylalkynyl)-4-benzylpiperidines.

Journal of medicinal chemistry·1999
Same author

The neuroprotective effect of the novel AMPA receptor antagonist PD152247 (PNQX) in temporary focal ischemia in the rat.

Stroke·1999
Same author

Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT1) transporters for PD 158473, an NMDA antagonist.

Pharmaceutical research·1999
Same author

Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity.

Journal of medicinal chemistry·1995
Same author

Potent, orally active, competitive N-methyl-D-aspartate (NMDA) receptor antagonists are substrates for a neutral amino acid uptake system in Chinese hamster ovary cells.

Journal of medicinal chemistry·1995

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Ionotropic glutamate receptors (iGluRs) are key mediators of excitatory neurotransmission in the central nervous system.
  • Their function relies on ligand-binding domains that undergo conformational changes upon agonist binding, leading to ion channel gating.
  • Understanding iGluR structure-function relationships is vital for deciphering synaptic transmission and neurological disorders.

Purpose of the Study:

  • To elucidate the structural basis of agonist binding and conformational changes in ionotropic glutamate receptors.
  • To investigate the role of macromolecular assemblies in receptor clustering and synaptic specificity.
  • To leverage novel pharmacological tools for a deeper understanding of kainate receptor function.

Main Methods:

  • Structural analysis of glutamate receptor subunits and their binding pockets.
  • Biophysical techniques to study agonist-induced conformational dynamics.
  • Biochemical assays to examine protein-protein interactions at the synapse.
  • Pharmacological profiling using selective agents for kainate receptors.

Main Results:

  • The glutamate-binding sites are formed by two extracellular domains within a single iGluR subunit.
  • Agonist binding triggers mechanical processes that directly influence ion gating and receptor desensitization.
  • Interactions with synaptic protein assemblies are critical for iGluR clustering and determining receptor specificity at the synapse.
  • Selective pharmacological agents are proving instrumental in dissecting kainate receptor mechanisms.

Conclusions:

  • The structural organization of iGluR binding sites dictates their functional responses to glutamate.
  • Synaptic protein interactions play a significant role in organizing and specifying iGluR function.
  • Advances in kainate receptor pharmacology are essential for future therapeutic strategies targeting neurological conditions.

Related Experiment Videos